| Names | |
|---|---|
| IUPAC name 4-[(E)-{4-formyl-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]pyridin-2-yl}diazenyl]benzene-1,3-disulfonic acid | |
| Other names PPADS | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChEBI | |
| ChemSpider | |
| UNII | |
| |
| |
| Properties | |
| C14H14N3O12PS2 | |
| Molar mass | 511.37 g·mol−1 |
| Appearance | Orange solid |
| 100 mM (tetrasodium salt)[1] | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
PPADS (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid) is a selective purinergicP2Xantagonist.[2] It is able to block contractions of rabbit vas deferens induced byATP or α,β,methylene-ATP. It appears to be relatively selective for P2X receptors, having no appreciable activity atα1 adrenergic, muscarinicM2 andM3, histamineH1, and adenosineA1 receptors.[3]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |